Cambridge Investment Research Advisors’s Inspire Fidelis Multi Factor ETF FDLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96M Buy
53,059
+29,891
+129% +$1.13M 0.01% 1604
2025
Q4
$828K Buy
23,168
+10,791
+87% +$380K ﹤0.01% 2257
2025
Q3
$432K Buy
12,377
+5,728
+86% +$190K ﹤0.01% 2806
2025
Q2
$211K Buy
+6,649
New +$193K ﹤0.01% 3308
2024
Q3
Sell
-6,809
Closed -$201K 3450
2024
Q2
$201K Sell
6,809
-1,904
-22% -$56.7K ﹤0.01% 3031
2024
Q1
$267K Buy
8,713
+1,792
+26% +$52.5K ﹤0.01% 2800
2023
Q4
$203K Sell
6,921
-3,968
-36% -$107K ﹤0.01% 2891
2023
Q3
$289K Sell
10,889
-1,982
-15% -$54.4K ﹤0.01% 2516
2023
Q2
$350K Buy
12,871
+4,000
+45% +$101K ﹤0.01% 2418
2023
Q1
$223K Buy
+8,871
New +$228K ﹤0.01% 2739

Other funds holding FDLS

Cambridge Investment Research Advisors's FDLS Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Inspire Fidelis Multi Factor ETF (FDLS) stake by 129% in Q1 2026, buying an estimated $1.13M and bringing the position to 53,059 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #1604.

Cambridge Investment Research Advisors first reported a position in FDLS in Q1 2023 and has held it in 10 quarters since. 37 funds tracked by Wall St. Rank hold FDLS as of Q1 2026.

  • Cambridge Investment Research Advisors held 53,059 shares of Inspire Fidelis Multi Factor ETF worth $1.96M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 29,891 Inspire Fidelis Multi Factor ETF shares in Q1 2026, an estimated $1.13M.
  • Inspire Fidelis Multi Factor ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1604 holding.
  • Cambridge Investment Research Advisors first reported a position in Inspire Fidelis Multi Factor ETF in Q1 2023 and has held it in 10 quarters since.
  • 37 funds tracked by Wall St. Rank held Inspire Fidelis Multi Factor ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.